Cargando…
Reply: Do we need biopsies of metastases for colorectal cancer patients?
Autores principales: | Frattini, M, Molinari, F, Saletti, P, Mazzucchelli, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720196/ http://dx.doi.org/10.1038/sj.bjc.6605170 |
Ejemplares similares
-
Do we need biopsies of metastases for colorectal cancer patients?
por: Floriani, I, et al.
Publicado: (2009) -
Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary
por: Yoshino, T, et al.
Publicado: (2012) -
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
por: Molinari, F, et al.
Publicado: (2009) -
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
por: Frattini, M, et al.
Publicado: (2007) -
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab
por: Epistolio, Samantha, et al.
Publicado: (2021)